Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashujit Tagde

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Signal Transduction and Targeted Therapy|May 16, 2018
Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancerMasayuki Hiraki, Takahiro Maeda, Neha Mehrotra, et al.
Cancer Research|December 22, 2017
MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast CancerTakahiro Maeda, Masayuki Hiraki, Caining Jin, et al.
JCI Insight|June 22, 2018
Targeting the human MUC1-C oncoprotein with an antibody-drug conjugateGovind Panchamoorthy, Caining Jin, Deepak Raina, et al.
Journal of Cellular and Molecular Medicine|May 16, 2018
MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanismDina Stroopinsky, Hasan Rajabi, Myrna Nahas, et al.
Blood|January 28, 2017
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemiaAthalia Rachel Pyzer, Dina Stroopinsky, Hasan Rajabi, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Signal Transduction and Targeted Therapy|May 16, 2018
Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancerMasayuki Hiraki, Takahiro Maeda, Neha Mehrotra, et al.
Cancer Research|December 22, 2017
MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast CancerTakahiro Maeda, Masayuki Hiraki, Caining Jin, et al.
JCI Insight|June 22, 2018
Targeting the human MUC1-C oncoprotein with an antibody-drug conjugateGovind Panchamoorthy, Caining Jin, Deepak Raina, et al.
Journal of Cellular and Molecular Medicine|May 16, 2018
MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanismDina Stroopinsky, Hasan Rajabi, Myrna Nahas, et al.
Blood|January 28, 2017
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemiaAthalia Rachel Pyzer, Dina Stroopinsky, Hasan Rajabi, et al.
Pageof 2